Posts Tagged ‘IHE’
-
Pharmaceutical ETFs: A Defensive Play in 2012?
April 25th by Tom Lydon
There are several obstacles that are facing the health care industry this year, as well as the...
-
Utilities, Consumer and Pharma ETFs Lead 2011
December 19th by Tom Lydon
Disruptions in the global economy have kept international equities suppressed, with a devastating...
-
Sector ETF Performance in 2011
November 6th by Tom Lydon
This year has been tough on stock exchange traded funds, especially those that track foreign...
-
Lower-Risk Stock ETFs to Consider
July 25th by Tom Lydon
Investors worried about choppy global economic growth and debt turmoil on both sides of Atlantic...
-
Biotech ETFs: Orexigen Hit By Regulatory Hammer
June 3rd by Tom Lydon
Biotech sector and related exchange traded funds (ETFs) trade lower as one drug maker garners...
-
Healthcare, Pharma ETFs Hit by Pfizer Decline
May 3rd by John Spence
A nearly 3% pullback in Pfizer (NYSE: PFE) after the drug giant reported flat quarterly revenue...
-
Pfizer to Weigh on Pharma, Healthcare ETFs
May 3rd by John Spence
Healthcare exchange traded funds (ETFs) will face an uphill climb Tuesday following quarterly...
